Clinical Trial Update: Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) [Phase 3]

View source ↗

Summary

A Phase 3 trial (ANRS120) evaluated alendronate versus placebo for HIV-associated osteoporosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Osteoporosis, HIV Infections | Phase 3 | Status: COMPLETED